Clinical Trial Update: Cytoflavin in the Treatment of Patients With Diabetic Polyneuropathy [Phase 3]

View source ↗

Summary

Phase 3 trial update on Cytoflavin for diabetic polyneuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathies
• Diabetic Polyneuropathy

Drugs mentioned

• Cytoflavin

Snippet

Sponsor: POLYSAN Scientific & Technological Pharmaceutical Company | Conditions: Diabetic Neuropathies | Phase 3 | Status: COMPLETED